XML 62 R43.htm IDEA: XBRL DOCUMENT v3.21.1
Income Taxes (Details Narrative) - USD ($)
12 Months Ended
Aug. 30, 2018
Mar. 23, 2018
Dec. 31, 2020
Dec. 31, 2019
Net operating loss carryforwards for federal tax purposes     $ 49,200,000  
Net operating loss carryforwards     2,700,000  
Cash received from related party   $ 3,200,000    
Gain sale of equity method investment   3,200,000 $ 354,000
Taxable gain   2,200,000    
Close merger cash amount   $ 955,000    
Proceeds from the sale of investment     354,000
Research and development tax credit carryforwards     $ 2,306,000 2,069,000
Domestic [Member]        
Net operating losses expiration date, description     The federal tax credits expire between 2028 and 2040, while the state tax credits have no expiration date.  
Research and development tax credit carryforwards     $ 1,300,000  
State [Member]        
Net operating losses expiration date, description     The federal tax credits expire between 2028 and 2040, while the state tax credits have no expiration date.  
Research and development tax credit carryforwards     $ 1,000,000  
GILTI [Member]        
Income tax rate deduction     50.00%  
Other Income Tax Matters [Member]        
Income tax description     Internal Revenue Code Section 382 places a limitation ("Section 382 Limitation") on the amount of taxable income that can be offset by net operating loss ("NOL") carryforwards after a change in control (generally greater than 50% change in ownership within a three-year period) of a loss corporation.  
California Purposes [Member]        
Net operating loss carryforwards for federal tax purposes     $ 41,000,000  
Net operating losses expiration date, description     Federal net operating losses generated on or prior to December 31, 2017, expire in varying amounts between 2028 and 2037, while federal net operating losses generated after December 31, 2017, carryforward indefinitely. The state net operating losses expire in varying amounts between 2028 and 2040.  
Lineage [Member]        
Percentage of ownership before transaction 80.40%      
Percentage of ownership after transaction 40.20%      
Juvenescence Limited [Member]        
Sale of common stock 14,400,000      
Ownership interest 5.60%      
Percentage of ownership before transaction 5.60%      
Percentage of ownership after transaction 45.80%      
LifeMap Sciences [Member]        
Net operating loss carryforwards for federal tax purposes     $ 8,900,000  
Net operating loss carryforwards     $ 6,200,000  
Ascendance [Member] | Stockholders [Member]        
Proceeds from the sale of investment       $ 354,000